ENTITY

Braveheart Bio (BRVE US)

9
Analysis
Health Care • United States
Braveheart Bio, Inc. is a clinical-stage biotechnology company. The Company focuses on developing therapeutics to treat hypertrophic cardiomyopathy (HCM) and related conditions by targeting overactive proteins within the heart. Braveheart Bio serves customers in the United States.
more
Exchange Announcement • 09 Sep 2026 04:08

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

Exchange Announcement • 09 Sep 2026 04:06

Current Report (Form 8-K | Period ending 2026-09-08)

Exchange Announcement • 07 Aug 2026 04:27

S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Exchange Announcement • 07 Aug 2026 04:20

424B4 | Prospectus

Exchange Announcement • 06 Aug 2026 07:38

S-1MEF | A new registration statement filed under Rule 462(b) to add securities to a prior related effective registration statement filed on Form S 1

No more filings
x